Medical Devices - NAFTA | Statista Market Forecast

The projected revenue for the Medical Devices market market in the North American Free Trade Agreement (in North American Free Trade Agreement (NAFTA)) is estimated to reach US$200.00bn by 2024.
Among the various markets, Cardiology_Devices is expected to be the largest, with a projected market volume of US$28.58bn in 2024.
Looking ahead, the market is anticipated to exhibit a compound annual growth rate (CAGR) of 5.29% between 2024 and 2029, resulting in a market volume of US$258.80bn by 2029.
Notably, the United States is expected to generate the highest revenue in the global comparison, with US$181.00bn in 2024.
The medical devices market in the NAFTA countries is experiencing significant growth due to increasing healthcare expenditure and technological advancements.

Definition:
The Medical Devices market includes instruments and machines helping for the prevention, diagnosis, and treatment of diseases. This market is further broken down into 6 submarkets according to medical specialties or types of application. Medical devices that treat the heart, such as pacemakers, can be found in the Cardiology Devices market. The Diagnostic Imaging market covers machines and instruments for diagnosis of many different kinds of conditions. Devices for orthopedic applications, such as joint implants, are included in the Orthopedic Devices market. Ophthalmic Devices are devices used for conditions related to the eye. The General & Plastic Surgery Devices covers many different products required for surgeries. The Other Medical Devices market provides information on additional areas that are not covered by the main markets.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Siemens Healthineers.

Implants and prostheses
Assistive technology products (e.g., hearing aids, wheelchairs)
Clinical engineering products
Imaging devices
Active medical devices (i.e., operating with electrical energy)

Services (i.e., treatment expenses)
Consumer technologies, e.g., fitness trackers
Products for laboratory testing (IVD)

The Medical Devices market in NAFTA is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all play a role in shaping the current state of the market.

Customer preferences: Customers in the NAFTA region have shown a strong preference for technologically advanced medical devices. They seek products that are innovative, efficient, and offer the latest advancements in healthcare. This preference is driven by the increasing awareness and demand for better healthcare outcomes, as well as the desire for improved patient experience. Customers also value devices that are user-friendly and easy to operate, as this enhances the overall efficiency of healthcare delivery.

Trends in the market: One of the key trends in the Medical Devices market in NAFTA is the growing demand for wearable devices. These devices, such as smartwatches and fitness trackers, are gaining popularity among consumers as they offer convenience and real-time monitoring of health parameters. This trend is driven by the increasing focus on preventive healthcare and the desire for individuals to take control of their own health. Additionally, there is a growing trend towards miniaturization of medical devices, which allows for greater portability and ease of use. Another trend in the market is the increasing adoption of telemedicine and remote patient monitoring. This is particularly relevant in the current global pandemic, where the need for remote healthcare services has become more prominent. Telemedicine allows for virtual consultations and remote monitoring of patients, reducing the need for in-person visits and improving access to healthcare services. This trend is expected to continue in the future, as it offers numerous benefits in terms of convenience and cost-effectiveness.

Local special circumstances: The Medical Devices market in NAFTA is also influenced by local special circumstances. For example, the healthcare systems in the NAFTA countries are characterized by a mix of public and private healthcare providers. This creates a unique market dynamic, as medical device manufacturers need to cater to the specific needs and requirements of both sectors. Additionally, regulations and reimbursement policies vary across the NAFTA countries, which can impact the adoption and usage of medical devices.

Underlying macroeconomic factors: The growth and development of the Medical Devices market in NAFTA are also influenced by underlying macroeconomic factors. Factors such as GDP growth, healthcare expenditure, and government initiatives play a crucial role in shaping the market. For example, countries with higher GDP growth and increased healthcare expenditure are likely to have a higher demand for medical devices. Similarly, government initiatives aimed at improving healthcare infrastructure and access to healthcare services can drive the demand for medical devices. In conclusion, the Medical Devices market in NAFTA is witnessing significant growth and development due to various factors. Customer preferences for technologically advanced devices, trends such as the adoption of wearable devices and telemedicine, local special circumstances, and underlying macroeconomic factors all contribute to the overall market dynamics. As the healthcare landscape continues to evolve, the market for medical devices in NAFTA is expected to further expand and innovate to meet the changing needs and preferences of customers.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.